spacer
home > epc > Summer 2016
PUBLICATIONS

European Pharmaceutical Contractor

epc
Summer 2016

   
Text
PDF
bullet
Business and Finance
Payer Negotiation

Coming to Terms

James Thomas
at Seren Partnership assesses the importance of negotiating skills in pharma, and reveals seven vital principles in dealing with payers that will prepare you for success.

 
view
download pdf
Clinical Training and Competence

Are You Qualified?


Competent staff are key to success in every business – this is especially true in pharma, where the stakes are higher. IAOCR’s Martin Robinson explains how competence-based training can aid enormously in further developing clinical research associates’ skills.

 
view
download pdf
bullet
Clinical Trials
GCP Compliance

Best of Both Worlds


There is a noticeable divide between clinical and quality, believes Patricia Santos-Serrao at MasterControl, and one of the ways to overcome this is the implementation of good management strategies.

 
view
download pdf
Electronic Trial Master Files

Paperweight Challenge


eTMFs are gaining more and more traction in the management of clinical trials, according to Veeva Systems’ Rik van Mol – it is not surprising, therefore, that demands placed on eTMFs have become increasingly higher.

 
view
download pdf
bullet
Clinical Trials Supplies
Sourcing Strategy

Going Local


Comparator drugs are increasingly taking the lead in the pharma supply chain, states Guillaume Brulebois at Fisher Clinical Services, and sourcing these from local markets seems to be the way forward. But is it that simple?

 
view
download pdf
Sourcing and Supply

Setting the Standard


Obtaining non-investigational medicinal products can pose a major challenge to stakeholders. Mary-Jo Lamberti, Josephine Awatin and Ken Getz at Tufts CSDD and Myoderm’s Michael Cohen explore some of the hurdles and share best practices in sourcing comparators.

 
view
download pdf
Spotlight

Demand-Driven Labelling and Distribution: What It Is and Why You May Need It

Clinigen CT
S introduces its new trial management system, designed to improve efficiency and save money for sponsors.

 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

A new market reference added to Safe’n’Sound®, our passive safety device platform

Safe’n’Sound® is on the market in Europe with a newly registered injectable medication. The commercial launch of HULIO™ (Adalimumab Biosimilar) was initiated in selected European markets on October 19,2018. Hulio™, developed by Fujifilm Kyowa Kirin Biologics Co., Ltd. and marketed in the European Union by Mylan N.V. is approved as a biosimilar for the same indications as the reference product, Humira®.
More info >>

White Papers

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

Eppendorf

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
More info >>

Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement